Meiji's September-quarter revenue rose 3.8%, supported by 2.8% growth in the domestic food segment as price revisions were implemented across its cocoa and dairy segments. Management raised its revenue guidance to JPY 1.2 trillion, but kept its operating income guidance of JPY 74 billion.
Meiji Holdings was established in 2009 as a merged entity of Meiji Dairies, Japan’s largest dairy company, and Meiji Seika, the country’s number-two confectionery maker. A surge in commodity prices, Japan’s aging and shrinking population, and fierce competition propelled the amalgamation. The food business—dairy, cacao, nutrition, and food solutions—represents about 80% of the group’s sales and 70% of profits. The rest comes from the pharmaceutical business, specializing in antibacterial and generic drugs, as well as vaccines. Overseas food operations, mainly in China, the US, and Southeast Asia, constitute merely 6.5% of the group's sales, which are in the red due to a surge in investment in China’s new factories and fierce price competition initiated by Chinese dairymakers.